Evidence map›Paper›PMID 25155589›Full record

ArticleAntimicrobial agents and chemotherapy2014

In vivo monitoring of Staphylococcus aureus biofilm infections and antimicrobial therapy by [18F]fluoro-deoxyglucose-MicroPET in a mouse model.

Victoria Garrido, María Collantes, Montserrat Barberán, Iván Peñuelas, Javier Arbizu, Beatriz Amorena, María-Jesús Grilló

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Covalent Lectin Inhibition and Application in Bacterial Biofilm Imaging.Angewandte Chemie (International ed. in English) · 2017
    Article
  10. Specific Imaging of Bacterial Infection Using 6″-Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2017
    Article
  11. In vitro imaging of bacteria usingScientific reports · 2017
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Victoria GarridoGrupo de Sanidad Animal, Instituto de Agrobiotecnología (CSIC-UPNA-Gobierno de Navarra), Mutilva, Navarra, Spain.
María CollantesUnidad de Investigación MicroPET, Center for Applied Medical Research (CIMA) and Clínica Universidad de Navarra, Pamplona, Spain.
Montserrat BarberánUnidad de Histología y Anatomía Patológica, Facultad de Veterinaria, Universidad de Zaragoza, Zaragoza, Spain.
Iván PeñuelasUnidad de Investigación MicroPET, Center for Applied Medical Research (CIMA) and Clínica Universidad de Navarra, Pamplona, Spain Servicio de Medicina Nuclear, Clínica Universidad de Navarra, Pamplona, Spain.
Javier ArbizuServicio de Medicina Nuclear, Clínica Universidad de Navarra, Pamplona, Spain.
Beatriz AmorenaGrupo de Sanidad Animal, Instituto de Agrobiotecnología (CSIC-UPNA-Gobierno de Navarra), Mutilva, Navarra, Spain.
María-Jesús GrillóGrupo de Sanidad Animal, Instituto de Agrobiotecnología (CSIC-UPNA-Gobierno de Navarra), Mutilva, Navarra, Spain mariajesus.grillo@unavarra.es.
Clinica Universidad de Navarra · ESGobierno de Navarra · ESAgrobiotechnology Institute · ESUniversidad de Zaragoza · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A mouse model was developed for in vivo monitoring of infection and the effect of antimicrobial treatment against Staphylococcus aureus biofilms, using the [(18)F]fluoro-deoxyglucose-MicroPET ([(18)F]FDG-MicroPET) image technique. In the model, sealed Vialon catheters were briefly precolonized with S. aureus strains ATCC 15981 or V329, which differ in cytotoxic properties and biofilm matrix composition. After subcutaneous implantation of catheters in mice, the S. aureus strain differences found in bacterial counts and the inflammatory reaction triggered were detected by the regular bacteriological and histological procedures and also by [(18)F]FDG-MicroPET image signal intensity determinations in the infection area and regional lymph node. Moreover, [(18)F]FDG-MicroPET imaging allowed the monitoring of the rifampin treatment effect, identifying the periods of controlled infection and those of reactivated infection due to the appearance of bacteria naturally resistant to rifampin. Overall, the mouse model developed may be useful for noninvasive in vivo determinations in studies on S. aureus biofilm infections and assessment of new therapeutic approaches.

Indexed as

AnimalsAnti-Bacterial AgentsBacterial AdhesionBiofilmsCatheters, IndwellingDisease Models, AnimalFemaleFluorodeoxyglucose F18MiceMicrobial Sensitivity TestsPositron-Emission TomographyRadiopharmaceuticalsRifampinStaphylococcal InfectionsStaphylococcus aureusAnti-Bacterial AgentsFluorodeoxyglucose F18RadiopharmaceuticalsRifampin

Identifiers

PMID25155589
PMCPMC4249392
OpenAlexW1971707593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.